NCT01685424 is a clinical trial of Etoricoxib in Osteoarthritis, sponsored by Organon and Co.

Who is sponsoring NCT01685424?

NCT01685424 is sponsored by Organon and Co.

What drugs are being tested in NCT01685424?

Interventions in NCT01685424: Etoricoxib.

What condition does NCT01685424 study?

NCT01685424 studies Osteoarthritis, Rheumatoid Arthritis, Ankylosing Spondylitis, Gout, Arthritis.

Is NCT01685424 still recruiting?

NCT01685424 is currently completed. Last updated 18 February 2022.

Last reviewed 2022-02-18 · How we verify

NCT01685424

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1)

Completed Last updated 18 February 2022

What this trial tests

trial testing Etoricoxib in Osteoarthritis in 79,189 participants. Completed in 1 March 2015.

Timeline

30 June 2006

Primary endpoint
1 March 2015

1 March 2015

Quick facts

Lead sponsor	Organon and Co
Status	Completed
Study type	OBSERVATIONAL
Enrollment	79,189
Start date	30 June 2006
Primary completion	1 March 2015
Estimated completion	1 March 2015

Drugs / interventions tested

Etoricoxib (ETORICOXIB) — full drug profile →

Conditions studied

Osteoarthritis — all drugs for Osteoarthritis →
Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →
Ankylosing Spondylitis — all drugs for Ankylosing Spondylitis →
Gout — all drugs for Gout →

Sponsor

Organon and Co — full company profile →

Who can join

Eligibility, any sex, with Osteoarthritis or Rheumatoid Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This postmarketing study was conducted to describe prescribing patterns for etoricoxib (ARCOXIA®) in General Practice and describe the incidence of selected adverse events recorded in the United Kingdom (UK) Medicines and Health Care Products Regulatory Agency (MHRA) General Practice Research Database (GPRD).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
Kroon FP, van der Burg LR, Ramiro S, Landewé RB, et al · · 2015 · cited 60× · PMID 26186173 · DOI 10.1002/14651858.cd010952.pub2

Verify or expand the search:

Other trials of Etoricoxib

Trials testing the same drug.

NCT07370532 — Etoricoxib in Patients With Parkinsonian Disease · Phase 2 · recruiting
NCT06001112 — Immediate Analgesic Effects of Cheek Acupuncture for Acute Gouty Arthritis · NA · completed
NCT04462666 — Oral Huzhang Granules for Acute Gouty Arthritis · Phase 2 · unknown
NCT04565600 — Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib · Phase 2 · completed
NCT01077843 — Post-authorization Safety Study of Etoricoxib and Other Anti-inflammatory Therapies in European Patients With Ankylosing · completed

Other recruiting trials for Osteoarthritis

Currently open trials in the same condition.

NCT07404891 — Clinical Trial on the Efficacy and Safety of ALT001 in Osteoarthritis · NA · recruiting
NCT07118501 — A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System · recruiting
NCT06631638 — EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN)) · NA · recruiting
NCT07198750 — "Bimodal vs Unimodal High-Intensity Pulsed Electromagnetic Field Therapy in Older Adults With Knee Osteoarthritis" · NA · recruiting
NCT07006714 — Preoperative Correction of Vitamin D Deficiency in Total Joint Arthroplasty (TJA) · Phase 4 · active not recruiting

Other Organon and Co trials

Trials by the same sponsor.

NCT05761444 — Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients · Phase 4 · completed
NCT05789576 — A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Regi · Phase 4 · completed
NCT05680740 — A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis · Phase 4 · completed
NCT05560646 — A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 · Phase 2 · completed
NCT05264506 — Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive · Phase 3 · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01685424 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Organon and Co
Last refreshed: 18 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01685424.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing